Sanofi in talks to sell generics arm Zentiva to Advent for 1.9 bn
Paris: French healthcare group Sanofi (SASY.PA) has started exclusive talks with private equity firm Advent Internati onal over selling its Zentiva European generics drugs arm to Advent for 1.9 billion euros (£1.6 billion), the companies said.
The planned sale of Zentiva began in October after Sanofi spent more than a year carving out the division in a bid to create a stand-alone company that could be sold to one of its competitors or to an investment fund.
Sanofi said the sale was expected to be completed before the end of the year, and that Advent’s offer for Zentiva was a binding one and was fully financed.
“Following a comprehensive review of strategic options for our generics unit in Europe, we have determined that transferring this business to Advent is the best option to ensure its long-term success,” Sanofi Chief Executive Olivier Brandicourt said in a statement.
The remark came in the wake of an interview Zarif gave to US' CBS TV news.
China said it welcomed plans by top US officials to visit the country to discuss trade.
Bloomberg, in a CBS interview, said he hopes by next year Trump will have changed his mind.
CPI(M) will not have a political alliance with Congress but an "understanding" inside and outside Parliament to stop the forces of communalism, Sitaram Yechury said.
China has agreed to resume sharing of hydrological data of the Brahmaputra and Sutlej rivers, External Affairs Minister Sushma Swaraj said.
Fugitive Indian diamond merchant Jatin Mehta asked the Indian government to reconsider his case after he got favourable judgments from international courts in Sharjah.
Worried his arrest is imminent, Nirav Modi has started selling off some of his international assets.
The US Attorney's Office in New York has filed federal terrorism charges against a bombing suspect who was accused of detonating a pipe bomb.
The embattled liquor baron Vijay Mallya once again offered to settle his Rs 9,000 crore debt with lenders.